Adult-onset Still's disease classification

Adult-onset Still's disease
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adult-onset Still’s Disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Template:Adult-onset Still's disease On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Template:Adult-onset Still's disease All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Adult-onset Still's disease classification
CDC on Template:Adult-onset Still's disease
Template:Adult-onset Still's disease in the news
Blogs on Template:Adult-onset Still's disease
Risk calculators and risk factors for Template:Adult-onset Still's disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Classification

Classification based on clinical presentation

Adult-onset Stiil's disease (AOSD) may be classified based on the predominant clinical picture with which the patient presents. The following are the sub-types:

• ASOD with pre-dominant systemic symptoms
• ASOD with pre-dominant arthritis

Adult-onset Still's disease sub-types	Systemic sub-type	Distinguishing features
		Pre-dominant cellular mechanism	Cytokine profile	Clinical presentation	Laboratory findings	Response to treatment	Miscellaneous
		Natural killer (NK) cell dysfunction (marked deficiency) CD8 type (cytotoxic) T cell dysfunction (marked deficiency) Neutrophil, monocyte and macrophage activation	Interleukin 1 beta Interleukin 18 Interferon alpha and beta Interleukin 4	Arhtraligia Myalgia Hepatitis Spleenomegaly Spiking fever (evening spike) Orbital inflammation Cardiac dysfunction Pulmonary dysfucntion Weight loss Sore throat Lymphadenopathy	Thrombocytopenia Hyperferritinemia	Strong response to interleukin-1 inhibitors Weak response to interleukin 18 inhibitors and interferon gamma inhibitors	Upregulation of genes involved in granulocyte formation
	Arthritis sub-type	Natural killer (NK) cell dysfunction (deficiency) CD8 type (cytotoxic) T cell dysfunction (deficiency) Neutrophil, monocyte and macrophage activation	Interleukin 17 Interleukin 23 Interleukin 6 Tumor necrosis factor alpha (TNF-alpha)	Involvement of wrist, ankle, elbow joints, proximal interphalyngeal joints (PIP) Arthralgia Myalgia Spiking fever Salmon-colored maculopapular rash Less common systemic and organ involvement	Thrombocytosis Arthritis	Strong response to interleukin 6 inhibitors Good response to TNF-alpha inhibitors Weak reponse to interleukin 17 inhibitors